Supplemental material
Cancer Biology & Therapy
Volume 19, 2018 - Issue 11
Research Paper
Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma
, , , 
, , , , , , , , , , , & show all
Ka Ming PangDepartment of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USAhttp://orcid.org/0000-0001-7262-3918View further author information
http://orcid.org/0000-0001-7262-3918View further author information, Alex PozhitkovCenter for Informatics, City of Hope National Medical Center, Duarte, CA, USAhttp://orcid.org/0000-0001-6566-6450View further author information
http://orcid.org/0000-0001-6566-6450View further author information, , , , , , , , , , & show allRelated Research Data
Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Source:
Frontiers Media S.A.
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Source:
Springer Science and Business Media LLC
A Human Dynamin-related Protein Controls the Distribution of Mitochondria
Source:
Rockefeller University Press
mdivi-1 as a Fission Inhibitor
Source:
Wiley
MET in the Driver's Seat: Exon 14 Skipping Mutations as Actionable Targets in Lung Cancer
Source:
Elsevier BV
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer.
Source:
Medknow
A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity.
Source:
The Company of Biologists
Response prediction to a multitargeted kinase inhibitor in cancer cell lines and xenograft tumors using high-content tyrosine peptide arrays with a kinetic readout
Source:
American Association for Cancer Research (AACR)
Drp1-Dependent Mitochondrial Fission Plays Critical Roles in Physiological and Pathological Progresses in Mammals.
Source:
MDPI AG
Regulators of mitochondrial dynamics in cancer.
Source:
Elsevier BV
Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells
Source:
Oxford University Press (OUP)
Inhibition of the met receptor in mesothelioma.
Source:
American Association for Cancer Research (AACR)
Molecular engineering solutions for therapeutic peptide delivery
Source:
Royal Society of Chemistry (RSC)
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL
Source:
Springer Science and Business Media LLC
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.
Source:
Informa UK Limited
Relevance to lung cancer
Source:
Informa UK Limited
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Source:
American Association for the Advancement of Science (AAAS)
Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.
Source:
Neoplasia Press Inc. Published by Elsevier Inc.
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
Source:
Springer Science and Business Media LLC
Mitochondria, Bioenergetics and Apoptosis in Cancer
Source:
Elsevier BV
ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells.
Source:
Springer Science and Business Media LLC
Understanding c-MET signalling in squamous cell carcinoma of the head & neck
Source:
Elsevier BV
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Source:
Springer Science and Business Media LLC
Linking provided by
